The Role of Vitamin D Sufficiency in the Formation of Benign Diseases of the Mammary Glands

  • Inoyatova Nodira Miranvarovna Associate Professor, PhD «Center for the development of professional skills of medical staff» of the Ministry of Health of the Republic of Uzbekistan Department of Obstetrics, Gynecology and Perinatal Medicine
  • Asatova Munira Miryusupovna Department of Obstetrics, Gynecology and Perinatal Medicine head of the department, Professor
Keywords: risk factors, vitamin D, dyshormonal diseases of the mammary glands, sonography of the mammary glands

Abstract

Benign diseases of the mammary glands, being a "mirror" of the hormonal background of a woman, create an unfavorable background for the development of breast cancer. A link has been established between the development of breast cancer and low blood levels of vitamin D in women. Given the above, the purpose of this study was to evaluate the status of vitamin D and the relationship with benign breast diseases. 111 women were examined, with the study of risk factors, with the determination of quantitative 25-OH vitamin D in blood serum and ultrasound examination of the mammary glands. All women were divided into two groups: group 1 - 78 women of reproductive age (22-49 years), group 2 - 33 women of menopausal age (50 years and older). The average age of group 1 was 37.8 years, group 2 - 54.9 years. 98.7% of women of reproductive age and 98% of postmenopausal women had vitamin D deficiency or insufficiency. The frequency of mastopathy according to ultrasound diagnostics was 61.5% in group 1 and 24.2% in group 2. In the group of women of reproductive age, benign diseases of the mammary glands were three times more common than in the group of older women, apparently, this is due to the presence of a hyper estrogen state. There are a lot of risk factors for the development of dyshormonal diseases of the mammary glands, vitamin D deficiency is one of them.

References

1. Ashbeck T.L. Bening breast biopsy diagnosis and subsequent risk of breast cancer / T.L. Ashbeck, R.D. Rosenberg, P.M.Stauber et all // Cancer Epidemiol. Biomarkers Prev. – 2007.-№16 (3). – P.467-472
2. ВОЗ. Рак молочной железы. 2021г. who.int
3. Зайдиева Я.З. Витамин Д и фертильность: систематический обзор. Медицинский алфавит №6/2018, том №1 стр.24-33.
4. Клинические рекомендации Российского общества онкомаммологов по профилактике рака молочной железы, дифференциальной диагностике, лечению предопухолевых и доброкачественных заболеваний молочной железы. Опухоли женской репродуктивной системы. - 2016г.- №3.- том 12. – Vol.12. – с.43-52
5. Кравченко Е.Н., Ожерельева М.А. Состояние молочных желез при гинекологических заболеваниях (литературный обзор)// Мать и дитя в Кузбассе. – 2014.- №2.- с. 19-23.
6. Мальцева Л.И., Гарифуллова Ю.В., Калинкина М.Г. Роль витамина D в снижении плотности молочных желез у женщин с диффузной формой мастопатии. Практическая медицина. - 2018. - Том 16, №6. - с. 111-117.
7. Pilz S., Dobnig H., Winklhofer-Roob B., Riedmiller G, Fisher JE, Seelhorst U, Wellnitz B, Boehm BO, Marz W. Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiology, Biomarkers and Prevention – 2008 – 171228-1233. (doi: 10.1158/1055-9965. EPI-08-0002)
8. Тагиева Т.Т. Факторы риска развития заболеваний молочных желез// Вестник РОНЦ им. Н.Н.Блохина РАМН. – 2007. – Т. 18, №2. – с. 68-73
9. Ших Е.В., Тихомиров С.В., Зайцева Т.А., Сегедина Е.М., Трейвиш Л.С. Анализ эффективности применения различных режимов дозирования и форм холекальциферола у пациентов с нарушением репродуктивной функции // Доктор.Ру. 2019. № 4 (159). С. 54–58.
Published
2022-04-07
How to Cite
[1]
Miranvarovna, I.N. and Miryusupovna, A.M. 2022. The Role of Vitamin D Sufficiency in the Formation of Benign Diseases of the Mammary Glands. International Journal on Integrated Education. 5, 4 (Apr. 2022), 58-61. DOI:https://doi.org/10.17605/ijie.v5i4.2934.
Section
Articles